written on 18.06.2014

CEO: New Novartis will be a lean, mean, profit-making machine


Remember how Novartis CEO Joe Jimenez vowed to improve the Swiss drugmaker's margins? Would have been there and done that, if the company's recent spate of deals had been done last year–by 2.5 percentage points, Novartis now says.